Sarcoma resection with and without vascular reconstruction: A matched case-control study

George A. Poultsides, Thuy B. Tran, Eduardo Zambrano, Lucas Janson, David G. Mohler, Matthew Mell, Raffi S. Avedian, Brendan C. Visser, Jason T. Lee, Kristen Ganjoo, E. John Harris, Jeffrey A. Norton

Research output: Contribution to journalArticlepeer-review

29 Scopus citations


Objective: To examine the impact of major vascular resection on sarcoma resection outcomes. Summary Background Data: En bloc resection and reconstruction of involved vessels is being increasingly performed during sarcoma surgery; however, the perioperative and oncologic outcomes of this strategy are not well described. Methods: Patients undergoing sarcoma resection with (VASC) and without (NO-VASC) vascular reconstruction were 1:2 matched on anatomic site, histology, grade, size, synchronous metastasis, and primary (vs. repeat) resection. R2 resections were excluded. Endpoints included perioperative morbidity, mortality, local recurrence, and survival. Results: From 2000 to 2014, 50 sarcoma patients underwent VASC resection. These were matched with 100 NO-VASC patients having similar clinicopathologic characteristics. The rates of any complication (74% vs. 44%, P=0.002), grade 3 or higher complication (38% vs. 18%, P=0.024), and transfusion (66% vs. 33%, P<0.001) were all more common in the VASC group. Thirty-day (2% vs. 0%, P=0.30) or 90-day mortality (6% vs. 2%, P=0.24) were not significantly higher. Local recurrence (5-year, 51% vs. 54%, P=0.11) and overall survival after resection (5-year, 59% vs. 53%, P=0.67) were similar between the 2 groups. Within the VASC group, overall survival was not affected by the type of vessel involved (artery vs. vein) or the presence of histology-proven vessel wall invasion. Conclusions: Vascular resection and reconstruction during sarcoma resection significantly increases perioperative morbidity and requires meticulous preoperative multidisciplinary planning. However, the oncologic outcome appears equivalent to cases without major vascular involvement. The anticipated need for vascular resection and reconstruction should not be a contraindication to sarcoma resection.

Original languageEnglish (US)
Pages (from-to)632-640
Number of pages9
JournalAnnals of Surgery
Issue number4
StatePublished - Jan 1 2015
Externally publishedYes


  • Morbidity
  • Mortality
  • Outcome
  • Recurrence
  • Sarcoma
  • Survival
  • Vascular reconstruction
  • Vascular resection

ASJC Scopus subject areas

  • Surgery


Dive into the research topics of 'Sarcoma resection with and without vascular reconstruction: A matched case-control study'. Together they form a unique fingerprint.

Cite this